Document is current
Any future updates will be listed below
-
Authors
Moray, Kusum V. https://orcid.org/0000-0002-9333-5672
Chaurasia, Himanshu https://orcid.org/0000-0003-3679-4415
Sachin, Oshima
Joshi, Beena
-
Funding
Funding for this research was provided by:
Department of Health Research India (S.11011/08/2017-HR)
- License Information
-
More Information
Article History
Received: 18 August 2020
Accepted: 6 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: Since this was part of a larger HTA study, ethical approval was sought for the entire HTA study.
: Not applicable. (As we did not collect individual patient data for this study).
: The manufacturers of Nexplanon/Implanon-NXT are stakeholders in the HTA project undertaken by the technical partner of HTA-In. Technical inputs about the product were obtained from the manufacturers, they had no other influence (financial or otherwise) over the team that worked on the HTA/the decision makers. The team declares no conflict of interest.
